5.07% -0.075

Nyxoah Sa (NYXH)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1077)

NYXH's Discussions on Twitter

Compare NYXH vs ISRG, BDX, RMD, ALC, MDLN

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
NYXH Nyxoah Sa	1.405	156.83M	17.85M	-96.93M	-88.29M	-2.4735
ISRG Intuitive Surgical Inc	399.62	130.41B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	181.71	48.44B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	224.58	31.49B	5.54B	1.52B	1.74B	10.37
ALC Alcon Inc	65.47	31.92B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	34.03	28.54B	29.14B	1.07B	1.05B	1.1956

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2023-07-31	開始されました	H.C. Wainwright	Buy
2023-07-19	開始されました	Robert W. Baird	Neutral
2022-04-21	開始されました	Oppenheimer	Outperform
2022-04-06	開始されました	Wolfe Research	Peer Perform
2021-12-21	再開されました	Cantor Fitzgerald	Overweight
2021-07-28	開始されました	Cantor Fitzgerald	Overweight

Nyxoah Sa (NYXH) 最新ニュース

Nyxoah Sa (NYXH) 財務データ

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Compare NYXH vs ISRG, BDX, RMD, ALC, MDLN

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa (NYXH) 最新ニュース

Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption? - Yahoo Finance

Nyxoah SA Actuals & Estimates (HAM:5YI) - TradingView

Gross profit of Nyxoah SA – HAM:5YI - TradingView

Price to book ratio of Nyxoah SA – HAM:5YI - TradingView

Nyxoah Begins U.S. Post-Approval Study of Genio Sleep Apnea Implant - finance.biggo.com

Cash per share of Nyxoah SA – HAM:5YI - TradingView

Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial - Yahoo Finance

Nyxoah implants first patient in BREATHE study of Genio - Yahoo

symbol__ Stock Quote Price and Forecast - CNN

Nyxoah Launches Major U.S. Post-Approval Study for Genio Sleep Apnea Device - TipRanks

Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System - GlobeNewswire

The trading volume of these stocks is deviating from the norm in today's session. - ChartMill

Nyxoah SA (NYXH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Cantor Fitzgerald reiterates Nyxoah stock rating on trial success By Investing.com - Investing.com Canada

Cantor Fitzgerald reiterates Nyxoah stock rating on trial success - Investing.com

Nyxoah stock rises on pivotal trial win for Genio (NYXH:NASDAQ) - Seeking Alpha

Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com India

NYXH Jumps As ACCCESS Trial Data Reset The Trading Map - timothysykes.com

NYXH Stock Jumps As ACCCESS Trial De‑Risks Sleep Apnea Bet - StocksToTrade

NYXH Stock Pops As ACCCESS Trial Data Fuels Breakout Hopes - timothysykes.com

NYXH Stock Jumps As ACCCESS Trial De-Risks U.S. Growth Story - StocksToTrade

87.7% improved on a measure of oxygen drops during sleep. No device-related serious adverse events were reported. - Stock Titan

Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary - GlobeNewswire

Nyxoah SA (NYXH) Stock Price & News - Syfe

Information on the total number of voting rights and shares - GlobeNewswire

Nyxoah (NYXH) Results Versus Estimates: The Available Earnings Metric Delivers a Miss in the Current Update; Market Reaction: The Share Price Sheds 2.74% in the Current UpdateEarnings Power Value - vinanet.vn

Nyxoah (NYXH) Latest: Falls 2.74% to $1.60 in Latest Trading; Price Context: the Current Price Sits Inside the Supplied Technical Range at the CloseIndex Put Call - vinanet.vn

Cantor Fitzgerald cuts Nyxoah stock price target on valuation By Investing.com - Investing.com Nigeria

Cantor Fitzgerald cuts Nyxoah stock price target on valuation - Investing.com

Cantor Fitzgerald Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat

NYXH Q2 2026 Earnings: EPS Miss of 46.48% Overshadowed by 2.53% Share GainCapex Guidance - vinanet.vn

Understanding Momentum Shifts in (NYXH) - Stock Traders Daily

Nyxoah (NASDAQ: NYXH) investors report 11.0M-share, 9.9% beneficial stake - Stock Titan

Nyxoah (NYXH) Q2 2026 Earnings: Wider-than-Expected Loss Flags Cost PressuresQuarterly Profit Report - dars.gov.et

Nyxoah SA (EBR:NYXH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - webull.com

Wall Street Zen Downgrades Nyxoah (NASDAQ:NYXH) to Sell - MarketBeat

A Quick Look at Today's Ratings for Nyxoah SA(NYXH.US), With a Forecast Between $2.31 to $6 - Moomoo

Nyxoah (NASDAQ:NYXH) Releases Earnings Results, Misses Expectations By $0.20 EPS - MarketBeat

Oppenheimer Adjusts Price Target on Nyxoah to $4 From $13, Maintains Outperform Rating - marketscreener.com

Nyxoah SA Stock 12‑Month Price Target Cut to $6, Implies 326% Upside - TradingView

Nyxoah SA Revenue Breakdown – EURONEXT:NYXH - TradingView

Piper Sandler Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $6 - Moomoo

Nyxoah Q2 Earnings Call Highlights - MarketBeat

Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results - The Manila Times

Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ... - Yahoo Finance

Nyxoah SA reports results for the quarter ended June 30Earnings Summary - TradingView

Nyxoah SA (NYXHB.XD) Q2 FY2026 earnings call transcript - Yahoo Finance

NYXH: Q2 2026 revenue surged 21% sequentially, with strong U.S. growth and robust outlook - TradingView

Earnings To Watch: Nyxoah SA (XBRU:NYXH) Q2 2026 -- GF Value Sees 5209% Upside - GuruFocus

Avoiding Lag: Real-Time Signals in (NYXH) Movement - Stock Traders Daily

Nyxoah SA (NYXH) Holds at $1.45 as Sleep Apnea MedTech Stock Tests Key Support ZoneOrder Block - dars.gov.et

Nyxoah Sa (NYXH) 財務データ

収益

当期純利益

現金流量

EPS

NYXHに似た銘柄